openPR Logo
Press release

Epigenetics Market to Reach $4.29 Billion by 2030, Fueled by Precision Medicine and Next-Gen Sequencing Advancements

04-27-2026 09:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Epigenetics Market to Reach $4.29 Billion by 2030, Fueled

Epigenetics Market by Product & Service (Enzymes, Kits & Reagents (Antibodies), Software), Method (DNA Methylation, Histone Modification), Technique (NGS, PCR), Application (Oncology, Immunology, Developmental Biology), End User - Global Forecast to 2030
According to MarketsandMarkets Trademark , the global Epigenetics Market [https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is on a strong growth trajectory, projected to expand from $2.24 billion in 2025 to $4.29 billion by 2030, registering a CAGR of 13.9%. This growth underscores the increasing strategic importance of epigenetic insights in precision medicine, drug discovery, and advanced diagnostics.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Browse

* 627 Market Data Tables
* 61 Figures
* 490 Pages and in-depth TOC on " Epigenetics Market - Global Forecast to 2030".

Rising investments in R&D, coupled with declining sequencing costs and faster turnaround times, are accelerating adoption across clinical and research environments. At the same time, the expansion of population-scale screening programs and growing demand for epigenetic-based therapeutics and diagnostics are reinforcing market momentum.

Kits & Reagents Segment Anchors Market Leadership

The kits & reagents segment dominated the market in 2024, with antibodies emerging as the most influential sub-segment. Their critical role in protein detection, gene expression analysis, and cellular regulation monitoring has made them indispensable tools in epigenetic workflows.

As research becomes increasingly data-driven and high-throughput, demand for reliable, scalable, and application-specific reagents is expected to surge-positioning this segment as a foundational revenue driver.

DNA Methylation Maintains Core Role in Epigenetic Research

Among methodologies, DNA methylation accounted for the largest market share in 2024 and continues to be a focal point for innovation-particularly in oncology.

Its proven utility in cancer biomarker discovery, disease progression analysis, and therapeutic targeting makes it one of the most commercially and clinically relevant epigenetic approaches. As oncology pipelines expand, DNA methylation-based solutions are expected to remain central to both research and clinical applications.

Asia Pacific Emerges as High-Growth Strategic Region

The Asia Pacific region is set to record the fastest growth during the forecast period, driven by:

*
Rapid improvements in healthcare infrastructure

*
Increasing R&D investments across emerging economies

*
Strategic collaborations and global expansion of regional players

*
Accelerated adoption of advanced technologies such as Next-Generation Sequencing (NGS)

These dynamics are transforming Asia Pacific into a key innovation and outsourcing hub for epigenetics research and development.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=896 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=896&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Competitive Landscape: Innovation and Integration at the Forefront

The market is highly competitive, with leading players focusing on technology integration, product innovation, and strategic partnerships to strengthen their global presence. Key companies include: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Danaher (US), Active Motif, Inc. (US), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Revvity (US), QIAGEN (Germany), among others.

These players are actively advancing NGS platforms, epigenetic assays, and bioinformatics solutions to address evolving research and clinical needs.

Executive Takeaway

For industry leaders, the epigenetics market represents a high-growth, innovation-driven opportunity at the intersection of genomics and precision medicine. Organizations that invest in scalable technologies, integrated solutions, and global expansion strategies will be best positioned to capture value in this rapidly evolving landscape.

Related Reports:

Genomics Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2030

Next-generation Sequencing Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=546&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2031

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=epigenetics-market-to-reach-429-billion-by-2030-fueled-by-precision-medicine-and-nextgen-sequencing-advancements]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epigenetics Market to Reach $4.29 Billion by 2030, Fueled by Precision Medicine and Next-Gen Sequencing Advancements here

News-ID: 4491441 • Views:

More Releases from ABNewswire

How to Choose China Wholesale Reformer Pilates Equipment for People's Studio?
How to Choose China Wholesale Reformer Pilates Equipment for People's Studio?
Picking out the right Reformer Pilates Equipment [https://www.luminefitness.com/reformer-pilates-equipment/] for your studio can honestly feel pretty overwhelming at times. I mean, as Sarah Johnson, who's been teaching and running her own studio for years, always says, "The right equipment can really change the game-making workouts both effective and fun." So, when you're shopping around, it's super important to think about things like quality, durability, and whether it actually works well for
How to Choose a Natural Herbal Body Wash?
How to Choose a Natural Herbal Body Wash?
Body wash is no longer just about "getting clean." As consumers increasingly embrace natural skincare philosophies, gentle, non-irritating herbal body washes that combine brightening, exfoliating, and long-lasting moisturizing benefits have become a major market trend. With countless options available, which one truly "solves three core needs-cleansing, brightening, and moisturizing-in one bottle"? Care Body Wash, a natural refreshing herbal body wash from Guangdong, China, offers the perfect solution for all skin
Best Natural Flea & Tick Collar for Dogs in 2026 - TryVertty.com Names DEWEL the Leading Chemical-Free Choice
Best Natural Flea & Tick Collar for Dogs in 2026 - TryVertty.com Names DEWEL the …
A 2026 review by TryVertty.com names DEWEL as the leading natural flea and tick collar for dogs, highlighting the growing shift toward chemical-free, long-lasting pet protection. As awareness around ingredient safety continues to grow, dog owners across the United States are increasingly seeking natural alternatives to traditional flea and tick prevention methods. In 2026, this shift is becoming more visible, with a rising number of pet owners prioritizing chemical-free solutions that
Latest Research on Capacitance Range in the Supercapacitor Market by MarketsandMarkets Trademark
Latest Research on Capacitance Range in the Supercapacitor Market by MarketsandM …
The global Supercapacitor Market Size in terms of revenue is estimated to be worth $1.35 billion in 2025 and is poised to reach $2.84 billion by 2030, growing at a CAGR of 16.1% during the forecast period. The report "Supercapacitor Market [https://www.marketsandmarkets.com/Market-Reports/supercapacitor-market-37140453.html?utm_source=abnewswire.com&utm_medium=PaidPR&utm_campaign=supercapacitormarket] by Type (Electric Double Layer Capacitors, Hybrid Capacitors, Pseudocapacitors), Capacitance Range (1,000 F), Electrode Material (Carbon, Composites, Metal Oxides, Conducting Polymers) - Global Forecast to 2030" The global supercapacitor

All 5 Releases


More Releases for Epigenetic

Nucleic Acid Therapeutics Market Trends Emphasizing Epigenetic and microRNA Modu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nucleic Acid Therapeutics Market - (By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Genetic Disorders, Infectious Diseases, Cancer, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Epigenetics Market - Harnessing the Epigenetic Revolution: Transforming the Futu …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Epigenetics Market. Epigenetics Market: https://www.growthplusreports.com/report/epigenetics-market/9171 The Epigenetics Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy. The Epigenetics market
Epigenetic Market 2021 | Detailed Report
The Epigenetic research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the Epigenetic industry to
Epigenetic Market Forecast By End-use Industry 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,
Epigenetic Market to Observe Strong Development by 2016-2026
The epigenetic process includes phosphorylation, methylation, sumolyation, acetylation and ubiquitylation etc. of DNA as well as histones resulting in changes in Phenotypes. These changes are modified with environmental conditions. Epigenetic market is now an emerging field. There are various diagnostic tests available now that detect epigenetic changes. There are some FDA approved epigenetic drugs. Other than many diagnostic companies, many biopharmaceutical and pharmaceutical companies are also very active in the
Epigenetic Market Plying for Significant Growth During 2016-2026
Epigenetic procedure involves stable changes in genome, which are reversible in gene expression. These changes can be transferred generation to generation, but contains no permanent changes in DNA. The epigenetically controlled genes are repressed or activated with no genotypic change in DNA. Epigenetic changes occur phenotypically but will have no genotypic change in the gene. This changes can occur naturally but can also be initiated by the environment changes, aging,